[go: up one dir, main page]

WO2006071843A3 - Biomarqueurs destines au cancer du sein - Google Patents

Biomarqueurs destines au cancer du sein Download PDF

Info

Publication number
WO2006071843A3
WO2006071843A3 PCT/US2005/047005 US2005047005W WO2006071843A3 WO 2006071843 A3 WO2006071843 A3 WO 2006071843A3 US 2005047005 W US2005047005 W US 2005047005W WO 2006071843 A3 WO2006071843 A3 WO 2006071843A3
Authority
WO
WIPO (PCT)
Prior art keywords
biomarkers
breast cancer
useful
classify
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/047005
Other languages
English (en)
Other versions
WO2006071843A2 (fr
Inventor
Vladimir Podust
Jacob Hendrik Beijnen
Marie-Christine Willemine Gast
Nathan Harris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VERENIGING HET NEDERLANDS KANKER INSTITUUT
Original Assignee
VERENIGING HET NEDERLANDS KANKER INSTITUUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VERENIGING HET NEDERLANDS KANKER INSTITUUT filed Critical VERENIGING HET NEDERLANDS KANKER INSTITUUT
Publication of WO2006071843A2 publication Critical patent/WO2006071843A2/fr
Anticipated expiration legal-status Critical
Publication of WO2006071843A3 publication Critical patent/WO2006071843A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne des biomarqueurs à base de protéines et des combinaisons de biomarqueurs utiles dans la qualification de l'état du cancer du sein chez une patiente. Par exemple, les biomarqueurs selon l'invention sont utiles pour classifier un échantillon d'un sujet selon qu'il est atteint ou non du cancer du sein. Les biomarqueurs peuvent être détectés par la spectrométrie de masse SELDI.
PCT/US2005/047005 2004-12-27 2005-12-27 Biomarqueurs destines au cancer du sein Ceased WO2006071843A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63837404P 2004-12-27 2004-12-27
US60/638,374 2004-12-27

Publications (2)

Publication Number Publication Date
WO2006071843A2 WO2006071843A2 (fr) 2006-07-06
WO2006071843A3 true WO2006071843A3 (fr) 2009-04-23

Family

ID=36615467

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/047005 Ceased WO2006071843A2 (fr) 2004-12-27 2005-12-27 Biomarqueurs destines au cancer du sein

Country Status (1)

Country Link
WO (1) WO2006071843A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007141595A2 (fr) * 2005-11-10 2007-12-13 Aurelium Biopharma Inc. Diagnostic tissulaire du cancer du sein
US20090325212A1 (en) * 2008-06-27 2009-12-31 Microsoft Corporation Data standard for biomaterials

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998058960A1 (fr) * 1997-06-22 1998-12-30 Yeda Research And Development Co. Ltd. PEPTIDES ISSUS DE LA SEQUENCE DU PEPTIDE COMPLEMENT C3a ET COMPOSITIONS ANTIALLERGIQUES LES COMPRENANT
US6274305B1 (en) * 1996-12-19 2001-08-14 Tufts University Inhibiting proliferation of cancer cells
WO2002006316A2 (fr) * 2000-07-14 2002-01-24 Zycos, Inc. Composes en rapport avec $g(a)-msh et methodes d'utilisation
US20020193332A1 (en) * 2001-02-12 2002-12-19 Hedley Mary Lynne Methods of treating bladder disorders
WO2003100439A2 (fr) * 2002-05-24 2003-12-04 University Of Sheffield Recepteur et methodes de criblage
WO2004090550A2 (fr) * 2003-04-08 2004-10-21 Colotech A/S Procede de detection d'un cancer colorectal dans des echantillons humains

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274305B1 (en) * 1996-12-19 2001-08-14 Tufts University Inhibiting proliferation of cancer cells
WO1998058960A1 (fr) * 1997-06-22 1998-12-30 Yeda Research And Development Co. Ltd. PEPTIDES ISSUS DE LA SEQUENCE DU PEPTIDE COMPLEMENT C3a ET COMPOSITIONS ANTIALLERGIQUES LES COMPRENANT
WO2002006316A2 (fr) * 2000-07-14 2002-01-24 Zycos, Inc. Composes en rapport avec $g(a)-msh et methodes d'utilisation
US7169603B2 (en) * 2000-07-14 2007-01-30 Mgi Pharma Biologics, Inc. α-MSH related compounds and methods of use
US20020193332A1 (en) * 2001-02-12 2002-12-19 Hedley Mary Lynne Methods of treating bladder disorders
WO2003100439A2 (fr) * 2002-05-24 2003-12-04 University Of Sheffield Recepteur et methodes de criblage
WO2004090550A2 (fr) * 2003-04-08 2004-10-21 Colotech A/S Procede de detection d'un cancer colorectal dans des echantillons humains

Also Published As

Publication number Publication date
WO2006071843A2 (fr) 2006-07-06

Similar Documents

Publication Publication Date Title
WO2007002535A3 (fr) Biomarqueurs pour le cancer des ovaires
IL251791B (en) Ovarian cancer biomarkers: ctap3-related proteins
WO2006099126A3 (fr) Biomarqueurs du cancer de l'ovaire et de l'endometre: la hepcidine
WO2006034032A3 (fr) Marqueurs biologiques destines au cancer du sein
WO2007035766A3 (fr) Biomarqueur servant a detecter un cancer de la prostate
WO2006089125A3 (fr) Méthodes de détection du cancer de l'ovaire
WO2009036427A3 (fr) Biomarqueurs du cancer de la prostate
WO2007016548A3 (fr) Procedes et compositions a base de micro-arn pour le diagnostic, le pronostic et le traitement du cancer du sein
WO2006108087A3 (fr) Dispositifs et procedes permettant d'enrichir et de modifier des cellules tumorales circulantes et d'autres particules
EP2574679A3 (fr) Procédés de pronostic carninoma hépatocellulaire in vitro
WO2011106709A3 (fr) Biomarqueurs épithéliaux pour pronostiquer un cancer
WO2008061020A3 (fr) Méthodes permettant de traiter, de diagnostiquer ou de détecter un cancer
WO2006074360A3 (fr) Isoforme d'apolipoproteine a-ii utilisee en tant que biomarqueur pour le cancer de la prostate
WO2006128082A3 (fr) Biomarqueurs du cancer du sein
WO2013057581A3 (fr) Biomarqueurs composites pour criblage, diagnostic et pronostic non invasifs de cancer colorectal
WO2007120787A3 (fr) Procede de traitement, de diagnostic ou de detection du cancer
WO2007079250A3 (fr) Dispositifs et procedes d'enrichissement et de modification de cellules tumorales circulantes et d'autres particules
WO2010053816A3 (fr) Biomarqueurs pour le diagnostic du cancer du sein
WO2007002527A3 (fr) Biomarqueurs pour le cancer de l'ovaire: la b2-microglobuline
HK1205558A1 (en) Methods and biomarkers for detection and prognosis of cervical cancer
WO2009058331A3 (fr) Biomarqueurs permettant la détection du cancer des ovaires à un stade précoce
WO2010078333A3 (fr) Indicateurs d'ions métalliques fluorescents à base de benzoxazole
WO2007002069A3 (fr) Biomarqueurs du cancer du sein
WO2009003082A3 (fr) Compositions immunologiques utilisées en tant que biomarqueurs et/ou agents thérapeutiques pour le cancer
WO2007056049A3 (fr) Profilage moleculaire de cancer

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05855546

Country of ref document: EP

Kind code of ref document: A2